INTRODUCTION
============

Chronic neck pain (CNP) is one of the most common causes of pain and disability. The prevalence of recurring CNP is approximately 15% in the adult population ([@b11-jer-12-4-346]). The condition increases disability, significantly reduces quality of life and has a considerable socioeconomic impact ([@b11-jer-12-4-346]; [@b19-jer-12-4-346]; [@b40-jer-12-4-346]; [@b41-jer-12-4-346]). Moreover, CNP increases work absenteeism and the consumption of medicinal products ([@b49-jer-12-4-346]). Neck disability decreases the daily physical activity of these patients and is one of the factors that perpetuate its chronicity ([@b41-jer-12-4-346]).

Nonspecific neck pain has no particular origin ([@b40-jer-12-4-346]) but is thought to result from joint and muscle structures ([@b28-jer-12-4-346]; [@b40-jer-12-4-346]). It has also been observed that atlantoaxial and zygapophyseal joints and the intervertebral cervical discs are involved in generating pain ([@b11-jer-12-4-346]), although numerous authors consider it a multifactorial disease ([@b28-jer-12-4-346]). The main contributing factors include age, poor posture, repetitive stress, and social and psychosocial factors, which can increase disability, stress and anxiety ([@b28-jer-12-4-346]).

Certain patients with chronic pain show signs of central sensitization and abnormal pain modulation, causing changes in the peripheral somatosensory function, the spinal cord and cerebral cortex ([@b26-jer-12-4-346]). [@b23-jer-12-4-346] showed that there are cortical changes in the primary somatosensory area (S1) in patients with nonspecific chronic back pain ([@b23-jer-12-4-346]). S1 is activated during the presentation of harmful stimuli, although it is thought that S1 also modulates the location and intensity of the pain and is an area with significant neuroplasticity ([@b23-jer-12-4-346]). These authors also demonstrated a negative correlation between pain intensity and brain connectivity, such that patients with greater pain had reduced functional connectivity ([@b23-jer-12-4-346]).

A number of authors have demonstrated that if a somatosensory disorder is generated (by performing a specific task) then this will directly cause changes in motor learning due to their interrelation ([@b45-jer-12-4-346]). These changes in the central nervous system can affect the pain intensity, the pressure pain threshold and the reported pain ([@b43-jer-12-4-346]).

Currently, we know that chronic pain can last far longer than the initial disease and that social and psychological factors can influence its perpetuation. Thus, the learning of new experiences can modify the acquired pathological behaviors, thereby decreasing the perception of pain and the disability ([@b49-jer-12-4-346]).

The observation of activities can produce changes in the representation of the motor cortex ([@b6-jer-12-4-346]), given that observation reinforces the cortical representation of the action ([@b9-jer-12-4-346]). [@b27-jer-12-4-346] demonstrated that action-observation (AOb) therapy improves strength and functionality in patients with chronic disease ([@b27-jer-12-4-346]).

It has been suggested that visual training creates the necessary conditions for functional recovery based on the mirror-neuron system ([@b34-jer-12-4-346]). The mirror neurons are a specific class of neurons that are activated both in the execution of a movement itself and in the observation of the same or similar motion executed by another individual ([@b37-jer-12-4-346]). Several studies have shown that this specific neuronal network is activated by learning the movement through motor execution, observation, imitation, or imagination ([@b37-jer-12-4-346]; [@b46-jer-12-4-346]).

This neuronal system is found primarily in the inferior parietal lobule and in the inferior frontal gyrus ([@b29-jer-12-4-346]) but is also found in the primary motor cortex, secondary motor cortex, premotor cortex, and supplementary motor area ([@b34-jer-12-4-346]; [@b37-jer-12-4-346]).

Recent studies have shown that the observation of an action increases corticospinal excitability in healthy adults when combined with the intent to imitate and with physical practice ([@b36-jer-12-4-346]; [@b37-jer-12-4-346]; [@b44-jer-12-4-346]). Other studies have asserted that repeated observation of a movement model is effective for improving the performance of this motor ability ([@b17-jer-12-4-346]; [@b35-jer-12-4-346]; [@b48-jer-12-4-346]). The process that causes this change is still unknown, but there is evidence that the premotor cortex and the inferior parietal lobule are activated by observing or performing the same movement ([@b35-jer-12-4-346]).

There are two lines of research that show the hypothetical relationship between the activation of the motor system during AOb therapy and the adaptation of this system after repeating the AOb ([@b35-jer-12-4-346]): (a) there is increased activity of the corticospinal system during observation ([@b10-jer-12-4-346]; [@b35-jer-12-4-346]) and (b) there are changes in the primary motor cortex after observing a repeated action ([@b35-jer-12-4-346]; [@b44-jer-12-4-346]). [@b35-jer-12-4-346] demonstrated that there is a positive correlation between the amount of change in the cortical representation of the movement and the degree of corticospinal activation during the observation of a repeated action.

The main objective of this pilot study was to determine whether intervention through observed activities improves the cervical range of motion (CROM) in patients with nonspecific CNP. The secondary objective was to determine the effect of the intervention on the pressure pain detection threshold (PPDT) in these patients.

MATERIALS AND METHODS
=====================

To ensure the methodological quality of the study, as well as to adapt to the international criteria for presenting clinical reports, we followed the points of the CONSORT list ([@b39-jer-12-4-346]).

Design
------

The study was a double-blind, randomized pilot study. The randomization was performed by an individual external to the study, prior to the start of the study, using GraphPad QuickCalcs (GraphPad Software Inc., La Jolla, CA, USA). The intervention group was hidden from the blinded evaluator using an opaque envelope. The evaluator was thus unaware at all times as to which group the next patient belonged to. The study was approved by the Ethics Committee of La Paz University Hospital (HULP) (Code 4054). All patients completed the informed consent process before starting the study.

Selection criteria
------------------

Patients with CNP between the ages of 18 and 60 yr were recruited for the study, which was conducted in the Functional Rehabilitation Institute of the La Salle Centre for University Studies and in the HULP Physical Therapy Unit from October 2013 to June 2014.

The selection criteria were as follows: nonspecific CNP and between 18 and 60 yr of age. Exclusion criteria were cervical osteoarthritis or polyarthrosis, rheumatic disease, history of cervical hernia, whiplash syndrome, surgery on the neck, face or shoulders, systemic disease, medical history of cancer, significant trauma that the patient relates to their pain and/or refusal to participate. Once the candidate's suitability for the study had been checked, the participant was issued a number in ascending order and randomly assigned to one of the treatment groups.

Intervention
------------

The patients were divided into two groups, an effective movement group and an ineffective movement group. Each patient was assigned a number for performing the blinding. The intervention consisted of a single session during which three measurements were performed: pretreatment, posttreatment and 10 min after the second measurement.

Effective movement group
------------------------

The participants assigned to this group were shown a 1-min video showing an individual performing a cervical rotation movement to each side, first 10 times towards the right and then 10 times towards the left. The movement was performed effectively over the entire course of the cervical path, approximately 80°.

Ineffective movement group
--------------------------

The participants assigned to this group were shown a 1-min video showing an individual performing a cervical rotation movement ineffectively, without achieving the maximum cervical travel, performing approximately 40°. First, 10 movements towards the right were performed and then 10 towards the left.

The randomization was performed in a hidden manner, so that the evaluator knew the number corresponding to each subject but not the treatment group to which they belonged.

Double-blind
------------

To perform the blinding of the evaluator, a study assistant played the video assigned to each subject without the evaluator being present. After the video presentation, the evaluator returned to the treatment room to complete the subsequent and 10-min measurements.

The patient blinding consisted of not having the patient aware at any time as to whether the video they observed was the effective or ineffective movement. To facilitate the blinding, the individual appearing in the videos was the same model throughout and showed no indication of pain or disability, and the video was played in silence for all of the patients. This blinding was checked upon completion of the trial by asking the patients which video they thought they had observed, to which they replied that they had only watched a video of an individual moving their neck without specifying anything more.

Significant efforts were undertaken to avoid biases in the study. In addition to conducting double-blinding of the evaluator and participants, the treatment was always performed in the same room, measuring the confounding variables to control the sample and using the same material. The order in which the measurements were performed was consistent, as was the time during which the participants had to think about the action that they had observed.

Description of the outcome variables
------------------------------------

After each patient had given their informed consent to participate in the pilot study, they were given a battery of questionnaires to be filled out on the first day of measurement. These included several self-reports on psychological variables and a questionnaire on demographic variables that collected information on age, weight, height, medication, and pain chronicity and intensity. We assessed the psychological variables using the self-reported measurements. Catastrophism was assessed with the version of the Pain Catastrophizing Scale translated and validated in Spanish ([@b13-jer-12-4-346]); fear of movement was measured with the Spanish version of the Tampa Scale for Kinesiophobia (TSK-11) ([@b14-jer-12-4-346]); fear avoidance beliefs were assessed with the Spanish version of the Fear Avoidance Belief Questionnaire ([@b24-jer-12-4-346]); depressive symptoms were assessed with the Beck Depression Inventory; anxiety was assessed with the Spanish version of State-Trait Anxiety Inventory ([@b33-jer-12-4-346]); and neck disability was assessed with the Spanish version of the Neck Disability Index ([@b1-jer-12-4-346]).

Cervical joint range of motion
------------------------------

To quantify this movement, we used a CROM tool validated by [@b2-jer-12-4-346] that assessed the active movement of the cervical spine. The patient was seated in a chair, and the goniometer was placed on their head. The patient was then asked to perform the maximum flexoextension movement, lateral inclinations and rotations. Each movement was recorded twice; if the difference exceeded 5°, a third measurement was conducted.

Pressure pain detection threshold
---------------------------------

This was defined as the minimal amount of pressure that the patient perceived as painful. The tool used was an algometer (model Fx. 25 Force Gage, Wagner Instruments, Greenwich, CT, USA), which consists of a 1-cm^2^ rubber tip attached to a pressure meter. The data were collected in kg/cm^2^, with a 30-sec interval between each measurement, thereby avoiding the temporal summation of stimuli. This apparatus is a highly effective and clinically valid instrument for this purpose ([@b22-jer-12-4-346]).

Data analysis
-------------

The IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) was employed for the data analysis. We used the Shapiro--Wilk test to determine the normal data distribution. To compare the means of the intergroup and intragroup CROM, we used the *t*-test for independent and related samples. For the comparison of the PPDT, we performed the Wilcoxon test for related samples and the Mann--Whitney *U*-test for independent samples. For all statistical comparisons, we used *P*\<0.05 as the criterion of significance, with a 95% confidence interval. Effect size was calculated through Cohen d for parametric variables as:
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RESULTS
-------

### Participants

The patients were recruited from February 2014 to May 2014. A total of 30 patients were recruited, two of whom were excluded for meeting one of the exclusion criteria. Twenty-eight patients with nonspecific CNP were selected for the pilot study; 14 were randomly assigned to the effective movement group and 14 were assigned to the ineffective movement group ([Fig. 1](#f1-jer-12-4-346){ref-type="fig"}). All variables assessed followed a normal distribution (*P*\>0.05), starting from a homogeneous sample, except for the PPDT values. There were no statistically significant differences in the demographic characteristics except for pain chronicity ([Table 1](#t1-jer-12-4-346){ref-type="table"}). Moreover, there were no statistically significant differences in the psychological control variables, except in the TSK-11 within the effective movement group ([Table 2](#t2-jer-12-4-346){ref-type="table"}).

### Intervention

#### Cervical joint range of movement

In terms of the intragroup analysis, significant changes only occurred in the effective movement group from the posttreatment to the 10-min measurement in both flexion (*P*=0.020) and extension (*P*=0.025). The *t*-test for independent samples was performed on the difference in means between the groups in cervical rotations and no statistically significant changes were found (*P*= 0.069).

The intergroup analysis observed significant changes in the cervical rotation movement, both at posttreatment (*P*=0.042; Cohen *d*=0.81) and at 10 minutes (*P*=0.019; Cohen *d*=0.9) ([Table 3](#t3-jer-12-4-346){ref-type="table"}).

#### Pressure pain detection threshold

There were no statistically significant changes in the intergroup data. Within the intragroup results, statistically significant results were obtained for the effective movement group in C2 joints by obtaining the median and interquartile range, between the pretreatment and 10-min posttreatment (pre, 0.610 \[0.268--1.345\]; 10-min post, 0.605 \[0.245--1.393\]; *P*=0.04), with greater hyperalgesia. In contrast, there were significant changes in the ineffective movement group for C5--C6 zygapophyseal joints for both pretreatment to posttreatment (pre, 0.650 \[0.274--1.099\]; post, 0.428 \[0.248--0.661\]; *P*=0.010) and for pretreatment to 10-min posttreatment (pre, 0.650 \[0.274--1.099\]; 10-min post, 0.405 \[0.291--0.824\]; *P*=0.041), with greater hyperalgesia ([Table 4](#t4-jer-12-4-346){ref-type="table"}).

DISCUSSION
==========

The principal hypothesis was that intervention with image observation therapy improves the CROM and produces a hypoalgesic effect in participants. Our results partially prove this hypothesis due to the observed increase in the cervical range of rotation and the increase in PPDT on a point in the upper cervical region after the intervention. However, we have insufficient scientific evidence to perform a theoretical comparison with our results. However, a study similar to ours performed by [@b31-jer-12-4-346] proposed an experiment for the observation and recognition of a cervical rotation motor task. The results showed that the intervention improved the CROM and decreased the pain intensity ([@b31-jer-12-4-346]). All of the results obtained in this research will be discussed in depth below.

Cervical range of motion
------------------------

Based on the results, we can confirm that effective AOb immediately improves the CROM in patients with nonspecific CNP. In our study, we obtained differences of 7° between the groups in the entire movement, with 6.1° being the minimum detectable change for the right rotation and 4.9° for the left rotation, as reported by [@b2-jer-12-4-346]. This change is produced in both the visualization of an AOb and the thinking process conducted by the patient.

Most studies do not interpret AOb as the only element influencing the participant but rather are directed towards demonstrating the neural processes that are generated. [@b42-jer-12-4-346] represented congruent and incongruent sequential images of movements of the right hand. The participants had to observe the visual sequence while simultaneously performing the movement with their right hand. The study achieved greater activation of the upper parietal lobe and primary visual cortex for the participants who watched the visual series and hand movements that were in disagreement than those who watched the sequential congruent version ([@b42-jer-12-4-346]). The authors showed that when there is a change in the relationship between the action performed and the images observed there is increased activation of the early visual areas ([@b42-jer-12-4-346]). This demonstration leads us to assume that the activation of the parietal areas and visual cortex are related to the AOb and the movement performed, serving as a basis for our study.

Moreover, [@b4-jer-12-4-346] showed that motor-visual interference is modulated through higher cognitive processes, in such a way that when we pay attention to our own actions, the actions performed by others have less interference than our own ([@b4-jer-12-4-346]). This leads to the possibility that the influence of our video could have been lower due to the fact that the therapy conducted was not accompanied by the participant's own movement.

Lastly, this type of treatment has also been used on patients with neurological involvement. [@b8-jer-12-4-346] showed that AOb therapy improved motor training and motor memory in patients with chronic stroke ([@b8-jer-12-4-346]). Thus AOb might create cortical changes and improve motor skills.

One of the researchers' main theories is that CROM is influenced by AOb thanks to the activation of the mirror-neuron system. A considerable number of neuroimaging studies have shown that this neural network is located in the ventral and dorsal areas of the premotor cortex, in the inferior frontal gyrus, in the temporal visual and posterior parietal regions and in the somatosensory cortex ([@b7-jer-12-4-346]; [@b20-jer-12-4-346]; [@b47-jer-12-4-346]).

The motor system is boosted due to 2 basic processes that are generated in AOb: the initial recognition of the action (through the temporoparietal circuit) and motor simulation (through the parietofrontal circuit) ([@b21-jer-12-4-346]; [@b47-jer-12-4-346]). Thus, motor simulation is useful when the observer must predict the AOb reference point in order to adjust their own action towards this reference point or to synchronize their own action ([@b47-jer-12-4-346]). [@b3-jer-12-4-346], studied the relationship between the motor system and AOb through cortical excitability. Their results indicated that the excitability of the motor system has a cyclic rhythm similar to that of AOb, which suggests a close relationship between the two processes.

If we analyze the results in more detail, the videos of the effective and ineffective movements produced an increase of 3° and a decrease of 4° in cervical rotation, respectively. This outcome suggests that observing an image of a movement conducted incorrectly creates maladaptive changes in these patients. This situation could be explained through two possible theories. On one hand, the presence of areas related to pain, called pain matrices, has been widely related to cognitive and memory processes. Chronic pain creates cortical dysfunctions in these areas, which might mean that the ineffective video is analyzed erroneously, creating a reduction in the movement ([@b18-jer-12-4-346]; [@b25-jer-12-4-346]). Another hypothesis is related to the change in psychological aspects that affect patients with chronic pain. Firstly, catastrophism is associated with increased activity in areas related to motor control ([@b15-jer-12-4-346]). Secondly, within the fear of movement variable, significant differences were obtained between the two groups, with greater fear in the ineffective movement group. This result suggests that the CROM results in this group were lower than after the intervention due to the interference of fear of movement. It should be noted that the fear of movement variable measured with the TSK-11 had differences between the two groups, with fear being greater in the ineffective movement group, suggesting that the results of the CROM in this group were lower after the intervention due to the interference of fear of movement. Current evidence related to CNP has shown that fear of movement is related to CROM and to the level of disability of this type of patient ([@b38-jer-12-4-346]).

This study analyzed the influence of AOb regarding the increase in joint range. There is considerable evidence of the cortical activation produced by this therapy; more studies are therefore needed to define the medium to long-term effects of AOb and that integrate this treatment in a motor training protocol, given that other types of mental practices such as motor imagery in combination with physical practice have been shown effective in improving joint range of movement ([@b16-jer-12-4-346]; [@b50-jer-12-4-346]).

Patients with chronic pain have altered somatosensory imagery areas of the brain, which causes a loss of representational areas and sensory impairment, triggering a distorted body image.

Tissue pain limits the range of movement of patients with neck pain, which when prolonged can trigger compensatory movements to reduce the pain, such as muscle contractions that increase the vicious cycle of cortical impairment of motor processing. Thus, the observation of a complete movement can produce neural motor images and trigger the specific motor cortex areas of the neck ([@b5-jer-12-4-346]).

One of the positive aspects of AOb is the minimum risk for the patient. Manual therapy, specifically high-velocity cervical techniques, causes effects on CROM similar to those obtained by this study but has a high risk of injuring the patient. This suggests that the use of AOb is an effective alternative for this type of high-velocity cervical technique.

Pressure pain detection threshold
---------------------------------

AOb affects the PPDT of patients with nonspecific CNP. It generates changes in C2, in the effective movement group (hypoalgesia), and in C5--C6 when visualizing the ineffective movement (hyperalgesia).

Once the effective movement is observed, the PPDT in C2 increased. Subsequent to the integration of the video, the process was conducted in reverse, decreasing the threshold towards initial parameters. This change can be explained through the observation of the video, where the atlantoaxial joint complex is designed to perform the maximum rotation in the horizontal plane, allowing for approximately 45° of axial rotation in both directions ([@b30-jer-12-4-346]). This is related to the increase in PPDT through AOb.

Moreover, when the participant observed the incorrect movement, the PPDT decreased and remained that way after the process of integration. This fact suggests that the observation of an incomplete movement produced greater negative effects than viewing a correct image.

Most current studies have investigated the cortical effects produced by AOb associated with the integration of a painful stimulus. [@b12-jer-12-4-346] explored the neural mechanisms that generate pain in the coding of visual stimuli ([@b12-jer-12-4-346]). The authors found that painful stimulation decreased performance in the visual coding of a surprise task, combined with reduced functional connectivity of the hypothalamus ([@b12-jer-12-4-346]). These results suggest that patients with chronic pain have a reduced capacity for reaction when faced with new stimuli. [@b32-jer-12-4-346] confirmed these results in patients with fibromyalgia. However, our results showed for the first time how AOb influences the PPDT without the support of a motor activity.

More studies are needed to interpret the effect of AOb on the PPDT in patients with CNP.

Limitations of the study
------------------------

There are limitations to consider when interpreting the results of this study. Firstly, the data obtained at this research are preliminary outcomes and they are useful to calculate the sample size for future research. In order to extrapolate accurate and representative results of a future clinical trial the sample size should be higher. Secondly, there is scarce literature related to this subject for designing the study. However, we believe that the methodology was developed correctly based on methodological models that have reported similar therapies. Thirdly, the video consists of only the observation of cervical rotation; we therefore cannot extend these results to the other cervical movement planes. Fourth, there was no short-term follow-up. More studies are needed to investigate this therapy in the medium to long term. Lastly, the therapy was limited to participants with nonspecific CNP; it is therefore difficult to generalize the results to other populations that differ from this group.

This pilot study reveals that effective AOb improves the CROM in patients with nonspecific CNP in a short period of time. Moreover, AOb creates a significant effect on the PPDT. However, more studies are necessary to investigate the influence of an observed ineffective action on these patients and that show whether this therapy is beneficial in a motor training protocol in the medium to long term.
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###### 

Demographic characteristics and baseline measures

  Characteristic              Effective movement group (n=14)                          Ineffective movement group (n=14)
  --------------------------- -------------------------------------------------------- --------------------------------------------------------
  Age (yr)                    29.50±9.66                                               29.86±12.89
  Sex, male:female            5 (35.7):9 (64.3)                                        2 (14.3):12 (85.7)
  Medication, yes:no          2 (14.3):12 (85.7)                                       6 (42.9):8 (57.1)
  Height (cm)                 172.00±9.58                                              162.64±7.28
  Weight (kg)                 62.00±12.11                                              60.68±8.75
  Body Mass Index (kg/m^2^)   20.76±2.06                                               23.05±3.87
  Chronicity (yr)             6.25±5.05[\*](#tfn2-jer-12-4-346){ref-type="table-fn"}   4.86±4.00[\*](#tfn2-jer-12-4-346){ref-type="table-fn"}
  Days of pain (mo)           20.71±10.19                                              22.86±7.47
  Pain intensity              18.00±14.92                                              26.50±16.71

Values are presented as mean±standard deviation or number (%).

*P*\<0.05.

###### 

Baseline characteristics of psychological variables

  Variable    Effective movement group (n=14)                           Ineffective movement group (n=14)
  ----------- --------------------------------------------------------- -----------------------------------
  FABQ        27.29±10.56                                               39.21±15.10
  PCS         12.64±8.85                                                12.86±7.50
  BDI         8.38±3.95                                                 9.36±4.91
  NDI         8.71±4.25                                                 12.00±4.72
  S-ANXIETY   23.50±4.93                                                23.29±4.45
  T-ANXIETY   26.00±5.99                                                25.64±4.50
  TSK-11      22.57±5.39[\*](#tfn5-jer-12-4-346){ref-type="table-fn"}   24.43±5.92

Values are presented as mean±standard deviation.

FABQ, Fear Avoidance Belief Questionnaire; PSC, Pain Catastrophizing Scale; BDI, Beck Depression Inventory; NDI, Neck Disability Index; S-ANXIETY, State Anxiety Inventory; T-ANXIETY, Trait Anxiety Inventory; TSK-11, Tampa Scale for Kinesiophobia short version.

*P*\<0.05.

###### 

Differences between groups for changes from baseline in patients range of motion score

  Range          Follow-up      Effective movement group   Ineffective movement group                           *P*-value
  -------------- -------------- -------------------------- ---------------------------------------------------- -----------
  Flexion        Pre            56.86±13.53                51.44±10.19                                          0.242
  Post           56.94±12.77    51.48±11.26                0.241                                                
  10-min post    53.46±13.31    50.51±7.71                 0.481                                                
                                                                                                                
  Extension      Pre            70.32±9.21                 66.99±14.87                                          0.483
  Post           72.36±9.99     65.21±14.37                0.139                                                
  10-min post    69.93±9.38     63.57±15.61                0.203                                                
                                                                                                                
  Lateral flex   Pre            84.21±17.66                84.19±15.43                                          0.997
  Post           85.39±16.04    80.71±12.78                0.401                                                
  10-min post    83.58±19.65    80.65±15.35                0.664                                                
                                                                                                                
  Rotation       Pre            133.09±16.41               125.15±17.89                                         0.231
  Post           136.58±18.18   123.00±15.26               0.042[\*](#tfn7-jer-12-4-346){ref-type="table-fn"}   
  10-min post    136.86±15.07   121.19±18.07               0.019[\*](#tfn7-jer-12-4-346){ref-type="table-fn"}   

Values are presented as mean±standard deviation.

*P*\<0.05.

###### 

Differences between and within groups for changes from baseline in patients pressure pain thresholds

  Measurement              Pre                    Post                   10-min Post            Wilcoxon test (*P*-value)                                     
  ------------------------ ---------------------- ---------------------- ---------------------- ----------------------------------------------------- ------- -----------------------------------------------------
  Suboccipital                                                                                                                                                
   Group A                 0.643 (0.335--1.176)   0.575 (0.304--1.108)   0.673 (0.277--1.163)   0.300                                                 0.109   0.683
   Group B                 0.528 (0.318--0.895)   0.433 (0.220--0.924)   0.398 (0.243--0.690)   0.140                                                 0.198   0.056
                                                                                                                                                              
   Mann-Whitney *U*-test   0.491                  0.476                  0.190                                                                                
                                                                                                                                                              
  C2                                                                                                                                                          
   Group A                 0.610 (0.268--1.345)   0.695 (0.258--1.483)   0.605 (0.245--1.393)   0.753                                                 0.315   0.040[\*](#tfn10-jer-12-4-346){ref-type="table-fn"}
   Group B                 0.525 (0.238--0.790)   0.385 (0.215--0.698)   0.385 (0.200--0.643)   0.142                                                 0.975   0.069
                                                                                                                                                              
   Mann-Whitney *U*-test   0.323                  0.161                  0.148                                                                                
                                                                                                                                                              
  C5--C6                                                                                                                                                      
   Group A                 0.630 (0.318--1.144)   0.701 (0.269--1.521)   0.673 (0.230--1.281)   0.443                                                 0.807   0.506
   Group B                 0.650 (0.274--1.099)   0.428 (0.248--0.661)   0.405 (0.291--0.824)   0.010[\*](#tfn10-jer-12-4-346){ref-type="table-fn"}   0.362   0.041[\*](#tfn10-jer-12-4-346){ref-type="table-fn"}
                                                                                                                                                              
   Mann-Whitney *U*-test   0.198                  0.301                  0.370                                                                                
                                                                                                                                                              
  Upper trapezius                                                                                                                                             
   Group A                 0.593 (0.370--1.221)   0.663 (0.295--1.203)   0.693 (0.286--1.096)   0.615                                                 0.950   0.875
   Group B                 0.638 (0.351--0.730)   0.603 (0.260--0.878)   0.505 (0.265--0.925)   0.683                                                 0.675   0.875
                                                                                                                                                              
   Mann-Whitney *U*-test   0.550                  0.550                  0.520                                                                                
                                                                                                                                                              
  Phalange                                                                                                                                                    
   Group A                 0.830 (0.398--1.401)   0.740 (0.463--1.255)   0.970 (0.425--1.535)   0.329                                                 0.315   0.507
   Group B                 0.760 (0.440--1.450)   0.795 (0.373--1.745)   0.765 (0.370--1.320)   0.925                                                 0.272   0.433
                                                                                                                                                              
   Mann-Whitney *U*-test   0.854                  0.730                  0.629                                                                                

Values are presented as median (range).

Group A, effective movement group; Group B, ineffective movement group.

*P*\<0.05.
